Covered recipient · General Payments record
ALICIA LAU
Eye and Vision Services Providers Optometrist
General Payments · PY2018–2024
$300,653.58
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $113,817.50 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Carl Zeiss Meditec, Inc. | $113,817.50 | 17 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Carl Zeiss Meditec, Inc. | $8,277.50 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262152 | CMS |
| Carl Zeiss Meditec, Inc. | $6,545.00 | 01/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262154 | CMS |
| Carl Zeiss Meditec, Inc. | $3,696.00 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262156 | CMS |
| Carl Zeiss Meditec, Inc. | $6,622.00 | 02/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262158 | CMS |
| Carl Zeiss Meditec, Inc. | $7,661.50 | 03/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262160 | CMS |
| Carl Zeiss Meditec, Inc. | $7,469.00 | 03/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262162 | CMS |
| Carl Zeiss Meditec, Inc. | $6,468.00 | 03/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262164 | CMS |
| Carl Zeiss Meditec, Inc. | $6,198.50 | 04/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262166 | CMS |
| Carl Zeiss Meditec, Inc. | $6,930.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262168 | CMS |
| Carl Zeiss Meditec, Inc. | $8,008.00 | 09/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262170 | CMS |
| Carl Zeiss Meditec, Inc. | $6,391.00 | 09/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262172 | CMS |
| Carl Zeiss Meditec, Inc. | $4,312.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262174 | CMS |
| Carl Zeiss Meditec, Inc. | $8,585.50 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262176 | CMS |
| Carl Zeiss Meditec, Inc. | $6,960.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262180 | CMS |
| Carl Zeiss Meditec, Inc. | $7,280.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262182 | CMS |
| Carl Zeiss Meditec, Inc. | $5,813.50 | 12/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262178 | CMS |
| Carl Zeiss Meditec, Inc. | $6,600.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153262184 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.